A New Weight-Loss Drug Just Outperformed Popular GLP-1s. Here’s What It Means for the Future of Health

Retatrutide, Eli Lilly’s new experimental drug, helped some participants lose up to 28 percent of their body weight in clinical trials.

Share This Article
Leave a Comment

Leave a Reply

Login